Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 15, 2019 - Issue
Submit an article Journal homepage
270
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial

Kaiming Zhuo1 First-episode Schizophrenia and Early Psychosis Program, Division of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
,
Yingying Tang1 First-episode Schizophrenia and Early Psychosis Program, Division of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Department of EEG and Imaging, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
,
Zhenhua Song1 First-episode Schizophrenia and Early Psychosis Program, Division of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
,
Yingchan Wang1 First-episode Schizophrenia and Early Psychosis Program, Division of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
,
Junjie Wang2 Department of EEG and Imaging, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
,
Zhenying Qian2 Department of EEG and Imaging, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
,
Hui Li2 Department of EEG and Imaging, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
,
Qiong Xiang1 First-episode Schizophrenia and Early Psychosis Program, Division of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
,
Tianyi Chen1 First-episode Schizophrenia and Early Psychosis Program, Division of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;3 Shanghai Hong Kou Mental Health Center, Shanghai, People’s Republic of China
,
Zhilei Yang1 First-episode Schizophrenia and Early Psychosis Program, Division of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;4 Shanghai Jia Ding Mental Health Center, Division of Psychotic Disorders, Shanghai, People’s Republic of China
,
Yifeng Xu1 First-episode Schizophrenia and Early Psychosis Program, Division of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;5 Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
,
Xiaoduo Fan6 Psychotic Disorders Program, UMass Memorial Medical Center, University of Massachusetts Medical School, Worcester, MA, USA
,
Jijun Wang1 First-episode Schizophrenia and Early Psychosis Program, Division of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Department of EEG and Imaging, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;5 Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
&
Dengtang Liu1 First-episode Schizophrenia and Early Psychosis Program, Division of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;5 Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 1141-1150 | Published online: 08 May 2019

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Weiwei Liang, Yu Huang, Xunmin Tan, Jing Wu, Jiajia Duan, Hanping Zhang, Bangmin Yin, Yifan Li, Peng Zheng, Hong Wei & Peng Xie. (2019) Alterations Of Glycerophospholipid And Fatty Acyl Metabolism In Multiple Brain Regions Of Schizophrenia Microbiota Recipient Mice. Neuropsychiatric Disease and Treatment 15, pages 3219-3229.
Read now

Articles from other publishers (18)

L. Felice ReddyShirley M. GlynnJessica E. McGovernCatherine A. SugarEric A. ReavisMichael F. Green. (2023) A Novel Psychosocial Intervention for Motivational Negative Symptoms in Schizophrenia: Combined Motivational Interviewing and CBT. American Journal of Psychiatry 180:5, pages 367-376.
Crossref
Gülay Taşdemir Yiğitoğlu, Nesrin Çunkuş Köktaş & Fatma Özgün Öztürk. (2023) Opinions of Depression Patients About Transcranial Magnetic Stimulation: A Qualitative Study. Journal of Radiology Nursing 42:1, pages 114-120.
Crossref
Xiuru Su, Haixia Liu, Xuan Wang, Xiuling Pan, Xuan Zhang, Xinyan Lu, Long Zhao, Yingnan Chen, Yujie Shang, Fengchun Wu & Meihong Xiu. (2023) Neuronavigated Repetitive Transcranial Stimulation Improves Neurocognitive Functioning in Veterans with Schizophrenia: A Possible Role of BDNF Polymorphism. Current Neuropharmacology 21:1, pages 142-150.
Crossref
Paulina Putko. 2023. Innovations in Biomedical Engineering. Innovations in Biomedical Engineering 113 118 .
Rasmus Lorentzen, Tuan D. Nguyen, Alexander McGirr, Fredrik Hieronymus & Søren D. Østergaard. (2022) The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: a systematic review and meta-analysis. Schizophrenia 8:1.
Crossref
Gülay Taşdemir Yiğitoğlu, Nesrin Çunkuş, Fatma Özgün Öztürk & Kıymet Sarıçay. (2021) Identification of the sociodemographic and clinical characteristics of the patients who have undergone transcranial magnetic stimulation in a psychiatry clinic: A retrospective descriptive design. Perspectives in Psychiatric Care 58:2, pages 682-690.
Crossref
Konstantinos Bonotis, Konstantinos Anargyros, Nikolaos Liaskopoulos & Anna-Maria Barlogianni. (2022) Evaluation of memory performance in patients with brain disorders following rTMS treatment. A systematic review. Clinical Neurophysiology 135, pages 126-153.
Crossref
Paul B. Fitzgerald & Z. Jeff DaskalakisPaul B. Fitzgerald & Z. Jeff Daskalakis. 2022. rTMS Treatment for Depression. rTMS Treatment for Depression 169 187 .
Tyler Scullen, Nikhil Teja, Seo Ho Song, Mitchell Couldwell, Chris Carr, Mansour Mathkour, Darrin J. Lee, R. Shane Tubbs & Robert F. Dallapiazza. (2021) Use of Stereoelectroencephalography Beyond Epilepsy: A Systematic Review. World Neurosurgery 155, pages 96-108.
Crossref
Na Wen, Lei Chen, Xuemeng Miao, Min Zhang, Yaoyao Zhang, Jie Liu, Yao Xu, Siyu Tong, Wei Tang, Mengpu Wang, Jiahong Liu, Siyao Zhou, Xinyu Fang & Ke Zhao. (2021) Effects of High-Frequency rTMS on Negative Symptoms and Cognitive Function in Hospitalized Patients With Chronic Schizophrenia: A Double-Blind, Sham-Controlled Pilot Trial. Frontiers in Psychiatry 12.
Crossref
R. Bodén, J. Bengtsson, E. Thörnblom, W. Struckmann & J. Persson. (2021) Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression – a randomized controlled trial. Journal of Affective Disorders 290, pages 308-315.
Crossref
Hong Gan, Junjuan Zhu, Kaiming Zhuo, Jianye Zhang, Yingying Tang, Zhenying Qian, Qiong Xiang, Xuan Li, Yongjun Zhu, Jinhong Wang, Jijun Wang & Dengtang Liu. (2021) High frequency repetitive transcranial magnetic stimulation of dorsomedial prefrontal cortex for negative symptoms in patients with schizophrenia: A double-blind, randomized controlled trial. Psychiatry Research 299, pages 113876.
Crossref
Nicole P. Sloan, Linda K. Byrne, Peter G. Enticott & Jarrad A. G. Lum. (2020) Non-Invasive Brain Stimulation Does Not Improve Working Memory in Schizophrenia: A Meta-Analysis of Randomised Controlled Trials. Neuropsychology Review 31:1, pages 115-138.
Crossref
Michael A. Cummings & Jennifer A. O’Day. (2021) Should electroconvulsive therapy (ECT) be banned for schizophrenia?. CNS Spectrums, pages 1-3.
Crossref
Domenico Sciortino, Alessandro Pigoni, Giuseppe Delvecchio, Eleonora Maggioni, Giandomenico Schiena & Paolo Brambilla. (2021) Role of rTMS in the treatment of cognitive impairments in Bipolar Disorder and Schizophrenia: a review of Randomized Controlled Trials.. Journal of Affective Disorders 280, pages 148-155.
Crossref
Siqian Zhong, Yiru Hu, Yu Fu, Liping Cao & Bin Zhang. (2020) Functional MRI in the effect of transcranial magnetic stimulation therapy for patients with schizophrenia: a meta-analysis protocol. BMJ Open 10:12, pages e038557.
Crossref
Mehmet Diyaddin Güleken, Taner Akbaş, Selime Çelik Erden, Veysel Akansel, Zeliha Cengiz Al & Ömer Akil Özer. (2020) The effect of bilateral high frequency repetitive transcranial magnetic stimulation on cognitive functions in schizophrenia. Schizophrenia Research: Cognition 22, pages 100183.
Crossref
Sujita Kumar Kar & Vikas Menon. (2020) Repetitive Transcranial Magnetic Stimulation in Persistent Auditory Hallucination in Schizophrenia: Predictors of Response. Current Behavioral Neuroscience Reports 7:4, pages 221-231.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.